Study protocol: double-blind, randomized, prospective, placebo controlled parallel group phase II study to investigate the effect of glycerol phenylbutyrate (GPB) on neurofilament light chain (NfL) levels in patients with corticobasal syndrome (CBS).
Saved in:
| Title: | Study protocol: double-blind, randomized, prospective, placebo controlled parallel group phase II study to investigate the effect of glycerol phenylbutyrate (GPB) on neurofilament light chain (NfL) levels in patients with corticobasal syndrome (CBS). |
|---|---|
| Authors: | Palleis C; Department of Neurology, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany. carla.palleis@med.uni-muenchen.de.; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany. carla.palleis@med.uni-muenchen.de.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany. carla.palleis@med.uni-muenchen.de.; Department of Neurology, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany, Marchioninistraße 15, 81377. carla.palleis@med.uni-muenchen.de., Weidinger E; Department of Neurology, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany., Maaß S; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.; Department of Neurology, TUM School of Medicine and Health, Technical University Munich, Munich, Germany., Linke M; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany., Brendel M; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; Department of Nuclear Medicine, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany., Stöcklein S; Department of Radiology, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany., Al Tawil A; Institut Für Medizinische Informationsverarbeitung, Biometrie Und Epidemiologie (IBE), LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany., Mansmann U; Institut Für Medizinische Informationsverarbeitung, Biometrie Und Epidemiologie (IBE), LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany., Teupser D; Institute of Laboratory Medicine, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany., Borst T; Pharmacy of the University Hospital Erlangen, Uniklinikum Erlangen, Erlangen, Germany., Heimke-Brinck R; Pharmacy of the University Hospital Erlangen, Uniklinikum Erlangen, Erlangen, Germany., Hemmer B; Department of Neurology, TUM School of Medicine and Health, Technical University Munich, Munich, Germany., Höglinger GU; Department of Neurology, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Bidner H; TUM School of Medicine and Health, Muenchner Studienzentrum (MSZ), Technical University Munich, Munich, Germany., Simons M; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; Department of Neurology, TUM School of Medicine and Health, Technical University Munich, Munich, Germany.; Institute for Stroke and Dementia Research (ISD), LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany., Levin J; Department of Neurology, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany. johannes.levin@med.uni-muenchen.de.; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany. johannes.levin@med.uni-muenchen.de.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany. johannes.levin@med.uni-muenchen.de. |
| Source: | Neurological research and practice [Neurol Res Pract] 2026 Jul 03; Vol. 8 (1). Date of Electronic Publication: 2026 Jul 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BMC Country of Publication: England NLM ID: 101767802 Publication Model: Electronic Cited Medium: Internet ISSN: 2524-3489 (Electronic) Linking ISSN: 25243489 NLM ISO Abbreviation: Neurol Res Pract Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42400090 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Study protocol: double-blind, randomized, prospective, placebo controlled parallel group phase II study to investigate the effect of glycerol phenylbutyrate (GPB) on neurofilament light chain (NfL) levels in patients with corticobasal syndrome (CBS). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Palleis+C%22">Palleis C</searchLink>; Department of Neurology, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany. carla.palleis@med.uni-muenchen.de.; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany. carla.palleis@med.uni-muenchen.de.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany. carla.palleis@med.uni-muenchen.de.; Department of Neurology, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany, Marchioninistraße 15, 81377. carla.palleis@med.uni-muenchen.de.<br /><searchLink fieldCode="AU" term="%22Weidinger+E%22">Weidinger E</searchLink>; Department of Neurology, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Maaß+S%22">Maaß S</searchLink>; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.; Department of Neurology, TUM School of Medicine and Health, Technical University Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Linke+M%22">Linke M</searchLink>; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Brendel+M%22">Brendel M</searchLink>; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; Department of Nuclear Medicine, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Stöcklein+S%22">Stöcklein S</searchLink>; Department of Radiology, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Al+Tawil+A%22">Al Tawil A</searchLink>; Institut Für Medizinische Informationsverarbeitung, Biometrie Und Epidemiologie (IBE), LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Mansmann+U%22">Mansmann U</searchLink>; Institut Für Medizinische Informationsverarbeitung, Biometrie Und Epidemiologie (IBE), LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Teupser+D%22">Teupser D</searchLink>; Institute of Laboratory Medicine, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Borst+T%22">Borst T</searchLink>; Pharmacy of the University Hospital Erlangen, Uniklinikum Erlangen, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Heimke-Brinck+R%22">Heimke-Brinck R</searchLink>; Pharmacy of the University Hospital Erlangen, Uniklinikum Erlangen, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Hemmer+B%22">Hemmer B</searchLink>; Department of Neurology, TUM School of Medicine and Health, Technical University Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Höglinger+GU%22">Höglinger GU</searchLink>; Department of Neurology, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Bidner+H%22">Bidner H</searchLink>; TUM School of Medicine and Health, Muenchner Studienzentrum (MSZ), Technical University Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Simons+M%22">Simons M</searchLink>; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; Department of Neurology, TUM School of Medicine and Health, Technical University Munich, Munich, Germany.; Institute for Stroke and Dementia Research (ISD), LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Levin+J%22">Levin J</searchLink>; Department of Neurology, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany. johannes.levin@med.uni-muenchen.de.; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany. johannes.levin@med.uni-muenchen.de.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany. johannes.levin@med.uni-muenchen.de. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101767802%22">Neurological research and practice</searchLink> [Neurol Res Pract] 2026 Jul 03; Vol. 8 (1). <i>Date of Electronic Publication: </i>2026 Jul 03. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMC%22">BMC </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101767802 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2524-3489 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225243489%22">25243489 </searchLink><i>NLM ISO Abbreviation: </i>Neurol Res Pract <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42400090 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s42466-026-00504-5 Languages: – Code: eng Text: English Titles: – TitleFull: Study protocol: double-blind, randomized, prospective, placebo controlled parallel group phase II study to investigate the effect of glycerol phenylbutyrate (GPB) on neurofilament light chain (NfL) levels in patients with corticobasal syndrome (CBS). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Palleis C – PersonEntity: Name: NameFull: Weidinger E – PersonEntity: Name: NameFull: Maaß S – PersonEntity: Name: NameFull: Linke M – PersonEntity: Name: NameFull: Brendel M – PersonEntity: Name: NameFull: Stöcklein S – PersonEntity: Name: NameFull: Al Tawil A – PersonEntity: Name: NameFull: Mansmann U – PersonEntity: Name: NameFull: Teupser D – PersonEntity: Name: NameFull: Borst T – PersonEntity: Name: NameFull: Heimke-Brinck R – PersonEntity: Name: NameFull: Hemmer B – PersonEntity: Name: NameFull: Höglinger GU – PersonEntity: Name: NameFull: Bidner H – PersonEntity: Name: NameFull: Simons M – PersonEntity: Name: NameFull: Levin J IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 07 Text: 2026 Jul 03 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2524-3489 Numbering: – Type: volume Value: 8 – Type: issue Value: 1 Titles: – TitleFull: Neurological research and practice Type: main |
| ResultId | 1 |